Skip to main content
Market intelligence
AXSMHealthcare

Axsome Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 11, 2026Roger JeffsDirectorSale572$247.65$141,656
Jun 10, 2026Susan MahonyDirectorSale600$241.70$145,017
Jun 10, 2026Mark ColemanDirectorSale643$249.00$160,107